Pattern reversal visual evoked potentials as a measure of visual pathway pathology in multiple sclerosis
- 1 October 2003
- journal article
- review article
- Published by SAGE Publications in Multiple Sclerosis Journal
- Vol. 9 (5), 529-534
- https://doi.org/10.1191/1352458503ms935rr
Abstract
Background: Pattern reversal visual evoked potentials (PRVEPs) have a well-documented role in diagnosis of multiple sclerosis (MS), but their value as a visual function surrogate remains controversial. Methods: We evaluated PRVEP in 37 patients with MS who were participating in a long-term follow-up study following a phase III trial of interferon b-1a (A vonex®). Patients were examined to determine the Kurtzke Extended Disability Status Score (EDSS), multiple sclerosis functional composite (MSFC), contrast letter acuity (CLA), and had cranial MRI scans to determine whole brain atrophy (BPF). PRVEP was evaluated for P100 latency, amplitude, and waveform morphology. Two summary scores were created: for Score A, abnormal latencies, morphologies, and amplitudes of each individual eye were added; for Score B, abnormal latencies, morphologies, and amplitude ratio between eyes was determined. Sixteen patients in this group also had PRVEP at the time they enrolled in the clinical trial, eight years previously. Results: A t the follow-up exam, over 75% of patients had abnormal PVEP parameters while visual acuity (VA) was abnormal only in 59%. Increased PRVEP latency over the eight-year period correlated with deterioration assessed by EDSS (P = 0.006), BPF (P = 0.0001), and MSFC (P = 0.0041). Score A was significantly correlated with EDSS, BPF, C LA, cognitive function, and quality of life assessed with the Sickness Impact profile. No correlation was seen with the MSFC. Conclusions: The results indicate that PRVEP measures MS-related patho logy, and can provide not only diagnostic but also prognostic information during evaluation of MS patients.Keywords
This publication has 25 references indexed in Scilit:
- Evolving Concepts in the Pathogenesis of Multiple Sclerosis and Their Therapeutic ImplicationsJournal of Neuro-Ophthalmology, 2001
- Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MSNeurology, 2001
- Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patientsMultiple Sclerosis Journal, 2000
- Evoked Potentials in Clinical Trials for Multiple SclerosisJournal of Clinical Neurophysiology, 1998
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosisAnnals of Neurology, 1996
- Serial evoked potentials in multiple sclerosis bouts. Relation to steroid treatmentNeurological Sciences, 1994
- Natural history of multiple sclerosisAnnals of Neurology, 1994
- Evoked potentials predict the clinical changes in a multiple sclerosis drug studyNeurology, 1987
- Serial Recordings of Multimodality Evoked Potentials in Multiple Sclerosis: A Four Year Follow-Up StudyCanadian Journal of Neurological Sciences, 1986
- Improvements in the accuracy of pattern visual evoked potentials in the diagnosis of visual pathway disease*Neuro-Ophthalmology, 1982